Estimation of Mediastinal Toxicities after Radiotherapy for Hodgkin Lymphoma-A Normal Tissue Complication Analysis of the HD16/17 Trial by the German Hodgkin Study Group.

Michael OertelPriska HölscherDominik Alexander HeringChristopher KittelMichael FuchsUwe HaverkampPeter BorchmannHans Theodor Eich

Published in: Cancers (2024)

Both the clinically observed and calculated toxicity rates corroborate the overall low-risk profile of radiotherapy for Hodgkin lymphoma. Further treatment individualization will be attempted in the future.

Keyphrases

hodgkin lymphoma
early stage
locally advanced
radiation therapy
radiation induced
study protocol
clinical trial
phase iii
squamous cell carcinoma
combination therapy
ultrasound guided